70th anniversary of Hanoi's Liberation Day Vietnam - Asia 2023 Smart City Summit Hanoi celebrates 15 years of administrative boundary adjustment 12th Vietnam-France decentrialized cooperation conference 31st Sea Games - Vietnam 2021 Covid-19 Pandemic
Home / Health & Education / Health
Second made-in-Vietnam COVID-19 vaccine to begin human trials after Tet
Anh Kiet 20:31, 2021/01/20
Covivac will be the second made-in-Vietnam vaccine to be tested on humans after Nanocovax.

A second Covid-19 vaccine developed by Vietnam, Covivac, is scheduled to be tested on humans after Tet holiday, the Ministry of Health (MoH) said on January 19.

Covivac, produced by the Institute of Vaccines and Medical Biology (IVAC), yesterday received approval from the MoH for human trials.

Covivac will be the second made-in-Vietnam vaccine to be tested on humans after the Nanogen Pharmaceutical Biotechnology JSC (NANOGEN) began trials last December of its Nanocovax.

 Nanocovax, produced by the Nanogen Pharmaceutical Biotechnology JSC, was Vietnam's first coronavirus vaccine to enter human trials. Photo: Kinhtedothi.vn


The first phase of the trials will require 120 volunteers aged 18-59 and without underlying health conditions, infectious diseases or allergies, the health ministry said.

The ministry added that the IVAC will coordinate with the National Institute of Hygiene and Epidemiology in Hanoi and the Hanoi Medical University to begin recruiting volunteers and prepare equipment and facilities for the trials since January 21.

The volunteers will receive the first shot after Vietnam’s traditional Lunar New Year, in mid-February. The second phase is expected to begin in April and the third in July or August.

According to Dr. Chu Van Men, director of Center for Clinical Trials and Bioequivalence under the Military Medical University’s, Vietnam expects to collect all necessary data on clinical testing by the end of 2021 before it can consider mass vaccination.

Vietnam’s health ministry is in talks with the UK Covid-19 vaccine developers AstraZeneca and Oxford University to buy 30 million doses. It is also seeking to buy from the US (Pfizer), Russia (Sputnik V) and China.

RELATED NEWS
TAG: Human trials second made-in-Vietnam Covid-19 vaccine pandemic
Other news
15:14, 2024/03/24
Hanoi accelerating efforts to reduce new tuberculosis cases
Hanoi has achieved the targets set in the National Strategy for TB Prevention and Control by 2020 with a vision of 2030, with 80% of TB cases detected and 92% of detected patients being cured of the disease.
13:44, 2024/03/10
Hanoi aims for 94.5% health insurance coverage this year.
Hanoi encourages enrollment in social and health ínsurance by increasing banking penetration to facilitate the payment of pensions or monthly social allowances.
18:36, 2024/03/06
Denmark helps Vietnam enhance primary health care
Cooperation between Vietnam and Denmark in the field of health is based on a common understanding that primary health care is crucial to ensure equitable access to health and to tackle the growing burden of noncommunicable diseases.
07:31, 2024/02/08
Hanoi hospitals to ensure quality healthcare during Tet
The move aims to ensure that emergency cases, road accident victims, and emergency births are given due care during the Tet holiday.
21:38, 2023/12/05
Vietnamese doctors master single-port endoscopy
Pediatric Surgery Ward at Hanoi-based Saint Paul General Hospital is one of two centers in the world to perform laparoscopic common bile duct surgery without complications.
16:03, 2023/11/19
EU Green Education: Significant to biodiversity protection in Vietnam
European member states hope that educational initiatives will raise students’ concerns about Vietnam’s rapidly disappearing biodiversity.